Quote Level 2 Charts News Trades Historical Financials Wiki Market In 3D Message Board

Enanta Pharmaceuticals, Inc. (ENTA)

$ 37.6334 ▼-1.4066 (-3.60%)
Volume: 150,492
Add ENTA To StreamerAdd ENTA To Streamer
Add ENTA To My StocksAdd ENTA To My Stocks
Add ENTA Price AlertAdd ENTA Price Alert
Bid Ask Last Traded Open Prev Close
37.63 37.71 1:54:16 PM EST 38.50 39.04
Day's Range 52-Wk Range Avg Volume EPS P/E
37.24 - 38.94 30.13 - 52.58 268,532 1.88 22.40
Market Cap Outstanding Float Dividend / Yield Ex-Div Date
770 18.71M 15.74M N/A N/A
Short Interest Short % of Float Insider B/S Inst % Owned Exchange
4.21M 26.71 % -33,250 76 % NASDAQ
Support 2 Support 1 Pivot Price Resistance 1 Resistance 2
$ 36.2378 $ 36.9356 $ 37.9378 $ 38.6356 $ 39.6378
Current Report Filing (8-k)
Edgar (US Regulatory) • Tue Aug 18,2015 4:07 PM
Statement of Changes in Beneficial Ownership (4)
Edgar (US Regulatory) • Tue Aug 11,2015 4:13 PM
Statement of Changes in Beneficial Ownership (4)
Edgar (US Regulatory) • Mon Aug 10,2015 4:32 PM
Quarterly Report (10-q)
Edgar (US Regulatory) • Mon Aug 10,2015 4:24 PM
Current Report Filing (8-k)
Edgar (US Regulatory) • Thu Aug 6,2015 4:07 PM
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2015
Business Wire • Thu Aug 6,2015 4:01 PM
Enanta Pharmaceuticals to Host Conference Call to Discuss Financial Results for the Fiscal Third Quarter & Nine-Months Ended ...
Business Wire • Thu Jul 30,2015 4:30 PM
Signet Jewelers Set to Join the S&P 500; PAREXEL International, Catalent to Join the S&P MidCap 400; Others to Join S&P Small...
PR Newswire (US) • Fri Jul 24,2015 6:10 PM
Enanta Pharmaceuticals Announces U.S. Regulatory Approval of TECHNIVIE™ (ombitasvir, paritaprevir and ritonavir) tablets
Business Wire • Fri Jul 24,2015 2:50 PM
Statement of Changes in Beneficial Ownership (4)
Edgar (US Regulatory) • Tue Jul 14,2015 4:20 PM
Statement of Changes in Beneficial Ownership (4)
Edgar (US Regulatory) • Tue Jul 14,2015 4:19 PM
Statement of Changes in Beneficial Ownership (4)
Edgar (US Regulatory) • Wed Jul 1,2015 4:11 PM
Link to ENANTA PHARMACEUTICALS INC Stock Price

Enanta Pharmaceuticals, Inc. Company Description


Enanta Pharmaceuticals Inc is a research and development focused biotechnology company. It uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field. URL: http://www.enanta.com

ENTA Intraday Stock Chart

1d 1m 3m 6m 1y 2y 5y


ENTA vs ETF alternatives
ETFsToday3mths1YrYTD
ENTA-3.60%-7.10%-5.89%-25.45%
SPY-2.20%-8.55%-3.61%-5.75%
RWL-2.22%-9.39%-4.04%-7.10%
PRF-2.42%-10.13%-7.10%-8.28%
IPD-2.72%-12.88%-7.94%-3.38%
EPS-2.49%-9.78%-5.77%-8.01%
XLY-2.01%-4.17%6.86%2.57%
SSO-4.42%-16.64%-53.55%-55.98%
Most Recent ENTA Videos
No ENTA Videos…



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.